AQR Capital Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-52,204
| Closed | -$927K | – | 2351 |
|
2018
Q3 | $927K | Sell |
52,204
-20,986
| -29% | -$373K | ﹤0.01% | 1732 |
|
2018
Q2 | $1.01M | Buy |
+73,190
| New | +$1.01M | ﹤0.01% | 1720 |
|
2015
Q4 | – | Sell |
-24,453
| Closed | -$112K | – | 2350 |
|
2015
Q3 | $112K | Sell |
24,453
-82,406
| -77% | -$377K | ﹤0.01% | 2119 |
|
2015
Q2 | $555K | Sell |
106,859
-87,141
| -45% | -$453K | ﹤0.01% | 1729 |
|
2015
Q1 | $1.22M | Sell |
194,000
-18,100
| -9% | -$113K | ﹤0.01% | 1330 |
|
2014
Q4 | $1.33M | Buy |
212,100
+157,200
| +286% | +$989K | ﹤0.01% | 1515 |
|
2014
Q3 | $334K | Buy |
54,900
+2,700
| +5% | +$16.4K | ﹤0.01% | 2126 |
|
2014
Q2 | $344K | Sell |
52,200
-421,880
| -89% | -$2.78M | ﹤0.01% | 2146 |
|
2014
Q1 | $11.3M | Buy |
474,080
+371,000
| +360% | +$8.83M | 0.03% | 550 |
|
2013
Q4 | $1.1M | Sell |
103,080
-137,364
| -57% | -$1.47M | ﹤0.01% | 1681 |
|
2013
Q3 | $3.21M | Sell |
240,444
-51,136
| -18% | -$682K | 0.01% | 1016 |
|
2013
Q2 | $3.83M | Buy |
+291,580
| New | +$3.83M | 0.01% | 975 |
|